Bio

Grant Harshbarger joined Bentley in 2015 as a healthcare-focused investment banker, having previously worked with the firm from 2001 to 2005. Prior to rejoining, Mr. Harshbarger served as a Managing Director and Med Tech Sector Head at RBS CITIZENS (The Royal Bank of Scotland), executing debt financings and engaging in M&A and Corporate Finance dialogues with RBSC’s Med Tech clients and selected private equity sponsors active in the sector. Prior to RBS, he initiated the Healthcare Investment Banking Group at CARIS & COMPANY (now B. Riley) including investment banking coverage of research clients in the specialty pharmaceutical, devices, diagnostics, healthcare IT and hospital sectors. Some of his other prior experience includes the hedge fund CITADEL, HCPF/BRENNER, DEAN WITTER REYNOLDS (now MORGAN STANLEY) and CHEMICAL BANK (now JP MORGAN). With over 26 years of investment banking experience, Mr. Harshbarger has advised companies in all sectors of healthcare. These clients have been in all stages of development, including (i) private companies seeking early stage venture capital, (ii) small/mid-cap companies seeking IPOs, PIPES, public offerings, M&A or recaps, and (iii) market-leading companies seeking syndicated financings (e.g., high yield bonds, equity-linked), or novel strategic acquisition ideas. Mr. Harshbarger holds a B.A. from BROWN UNIVERSITY and an M.B.A. from the WHARTON SCHOOL at the UNIVERSITY of PENNSYLVANIA.